SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001824293-24-000044
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:12
Documents
4
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A griproxystatementjune2024r.htm DEF 14A 166434
2 GRAPHIC image_2.jpg GRAPHIC 24263
3 GRAPHIC proxycard.jpg GRAPHIC 103920
4 GRAPHIC proxycard1.jpg GRAPHIC 106786
  Complete submission text file 0001824293-24-000044.txt   491615
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40034 | Film No.: 24931263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)